Drug profile · INN
crizanlizumab
ADAKVEO
crizanlizumab (ADAKVEO) is a p-selectin blocker.
EMA: unknown Blood and blood forming organs (B06) B06AX01
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — crizanlizumab
- Class
- Blood and blood forming organs (B06)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
crizanlizumab (ADAKVEO) is a p-selectin blocker.
Key facts
INN crizanlizumab
Brand ADAKVEO
Mechanism P-selectin blocker
Target P-selectin
Therapeutic class Blood and blood forming organs (B06)
ATC code B06AX01
Mechanism of action
P-selectin blocker
Primary target: P-selectin
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | unknown | — |
Related & competitor drugs
Frequently asked questions
What is crizanlizumab?
crizanlizumab (ADAKVEO) is a p-selectin blocker.
What is the brand name for crizanlizumab?
ADAKVEO is a marketed brand name for crizanlizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.